Sodium Chloride Hypertonicitysodium

According to the FDA label: Uses temporary relief of corneal edema

70,399 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Sodium Chloride Hypertonicity in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Sodium Chloride Hypertonicity adverse event reports by reporter sex
SexReports
Female37,387
Male26,603
Unknown69

By Age Group

View age group data as a table
Sodium Chloride Hypertonicity adverse event reports by reporter age group
Age groupReports
0-175,352
18-345,709
35-497,899
50-6413,693
65-749,916
75+7,095

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Sodium Chloride Hypertonicity. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Sodium Chloride Hypertonicity adverse event reports by reported outcome
OutcomeReports
Other Serious36,137
Hospitalization32,093
Non-Serious13,563
Death6,172
Life-Threatening4,787
Disability1,622

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Sodium Chloride Hypertonicity. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Sodium Chloride Hypertonicity adverse event reports by year
YearReports
19981
19991
20011
2004118
2005183
2006273
2007249
2008265
2009413
2010400
2011584
2012850
2013690
20141,147
20152,148
20163,096
20172,485
20183,594
20195,071
20206,379
20215,731
20227,388
20237,768
20249,496
20259,820
2026 (partial)2,248

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Sodium Chloride Hypertonicity

In FDA adverse event reports that mention Sodium Chloride Hypertonicity, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026